We are live on ! Find out more
FENC icon

Fennec Pharmaceuticals
FENC

90 hedge funds and large institutions have $99.6M invested in Fennec Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

1.65% more ownership

Funds ownership: 45.5% → 47.15% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less funds holding

Funds holding: 96 → 90 (-6)

17% less capital invested

Capital invested by funds: $120M → $99.6M (-$20M)

20% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 20

Holders
90
Holders Change
-6
Holders Change %
-6.25%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
38
Reduced
18
Closed
20
Calls
$138K
Puts
–
Net Calls
+$138K
Net Calls Change
+$137K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$3.09M
2
RA
Rosalind Advisors
Ontario, Canada
+$2.28M
3
BlackRock
BlackRock
New York
+$1.03M
4
PCM
Potomac Capital Management
New York
+$998K
5
CC
Cornerstone Capital
California
+$811K

Top Sellers

Rank Fund Capital Flow
1
ACA
Apis Capital Advisors
New York
-$1.57M
2
Marshall Wace
Marshall Wace
United Kingdom
-$983K
3
SCM
Solas Capital Management
Connecticut
-$606K
4
GJL
Gendell Jeffrey L
-$436K
5
SCM
Stonepine Capital Management
Oregon
-$385K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPG
76
Cornerstone Planning Group
New Jersey
$592 – – –
GI
77
GAMMA Investing
California
$517 -$224 -29 -26%
HFS
78
Hughes Financial Services
Virginia
$437 -$201 -26 -27%
Nisa Investment Advisors
79
Nisa Investment Advisors
Missouri
$283 – – –
EP
80
Essential Partners
California
$234 +$108 +14 +58%
TWC
81
TD Waterhouse Canada
Ontario, Canada
$173 – – –
AF
82
Allworth Financial
California
$142 +$178 +23 New
RIL
83
Rothschild Investment LLC
Illinois
$117 +$147 +19 New
TWD
84
True Wealth Design
Ohio
$111 +$131 +17 +1,700%
MCM
85
MAI Capital Management
Ohio
$111 +$139 +18 New
SS
86
Sunbelt Securities
Texas
$55 +$15 +2 +29%
FDCDDQ
87
Federation des caisses Desjardins du Quebec
Quebec, Canada
$36 – – –
WPA
88
Wealth Preservation Advisors
Tennessee
$31 +$39 +5 New
CIAM
89
Caitong International Asset Management
Hong Kong
$6 +$8 +1 New
IA
90
IFP Advisors
Florida
$6 +$8 +1 New
ACA
91
Apis Capital Advisors
New York
– -$1.57M -204,000 Closed
Marshall Wace
92
Marshall Wace
United Kingdom
– -$983K -127,693 Closed
SCM
93
Stonepine Capital Management
Oregon
– -$385K -50,000 Closed
HIM
94
Hillsdale Investment Management
Ontario, Canada
– -$339K -44,000 Closed
Arrowstreet Capital
95
Arrowstreet Capital
Massachusetts
– -$250K -32,460 Closed
Acadian Asset Management
96
Acadian Asset Management
Massachusetts
– -$207K -27,059 Closed
Millennium Management
97
Millennium Management
New York
– -$188K -24,402 Closed
Jane Street
98
Jane Street
New York
– -$185K -24,044 Closed
Point72 Asset Management
99
Point72 Asset Management
Connecticut
– -$164K -21,298 Closed
Renaissance Technologies
100
Renaissance Technologies
New York
– -$154K -20,000 Closed
1 2 3
4
5

FENC Hedge Fund Activity: Q1 2026 in Review

90 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q1 2026, worth a combined $99.6M — down 17% from $120M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of FENC and 16 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 38 added.

The largest buyer was AIGH Capital Management, adding an estimated $3.09M. The largest seller was Apis Capital Advisors, exiting entirely with an estimated $1.57M sold.

  • 90 institutional investors held Fennec Pharmaceuticals (FENC) as of Q1 2026, down from 96 in Q4 2025.
  • Funds reported $99.6M of Fennec Pharmaceuticals stock for Q1 2026, down 17% quarter-over-quarter.
  • 16 funds opened new Fennec Pharmaceuticals positions in Q1 2026 and 20 closed out, a net change of -4 holders.
  • The largest Fennec Pharmaceuticals buyer in Q1 2026 was AIGH Capital Management, an estimated $3.09M added.
  • The largest Fennec Pharmaceuticals seller in Q1 2026 was Apis Capital Advisors, an estimated $1.57M sold.

Based on aggregated 13F filings for Q1 2026.